Hangzhou Alltest Biotech Co., Ltd. Stock

Equities

688606

CNE1000053G6

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. 06:00:00 2024-05-08 pm EDT 5-day change 1st Jan Change
66.73 CNY -1.17% Intraday chart for Hangzhou Alltest Biotech Co., Ltd. +0.35% -2.73%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2022 3.39B 469M Sales 2023 755M 104M Capitalization 5.36B 742M
Net income 2022 1.18B 164M Net income 2023 181M 25.06M EV / Sales 2022 0.51 x
Net cash position 2022 3.79B 525M Net cash position 2023 2.76B 383M EV / Sales 2023 3.44 x
P/E ratio 2022
4.75 x
P/E ratio 2023
30.1 x
Employees 1,244
Yield 2022
9.58%
Yield 2023
-
Free-Float 33.28%
More Fundamentals * Assessed data
Dynamic Chart
China, HK stocks rise, led by property shares RE
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023. CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback announced on August 17, 2023, has closed with 1,030,000 shares, representing 1.32% for CNY 59.58 million. CI
Hangzhou Alltest Biotech Co., Ltd. agreed to acquire an unknown stake in Hangzhou Weisibo Medical Technology Co., Ltd. CI
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023. CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tranche Update on Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback Plan announced on August 17, 2023. CI
Hangzhou Alltest Biotech Co., Ltd.(XSSC:688606) added to S&P Global BMI Index CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Hangzhou Alltest Biotech Co., Ltd. announces an Equity Buyback for CNY 60 million worth of its shares. CI
Hangzhou Alltest Biotech Co., Ltd. authorizes a Buyback Plan. CI
Hangzhou Alltest Biotech Co., Ltd.'s Equity Buyback announced on July 22, 2022, has expired. CI
Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
More news
1 day-1.17%
1 week+0.35%
Current month+0.35%
1 month-2.46%
3 months+11.40%
6 months-10.31%
Current year-2.73%
More quotes
1 week
66.08
Extreme 66.08
69.93
1 month
64.80
Extreme 64.8
75.44
Current year
50.92
Extreme 50.92
75.44
1 year
46.02
Extreme 46.02
81.10
3 years
46.02
Extreme 46.02
159.40
5 years
46.02
Extreme 46.02
159.40
10 years
46.02
Extreme 46.02
159.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 14-06-30
Director of Finance/CFO 46 14-06-30
Chief Operating Officer 43 14-03-31
Members of the board TitleAgeSince
Chief Executive Officer 50 14-06-30
Director/Board Member 50 14-09-30
Chief Operating Officer 43 14-03-31
More insiders
Date Price Change Volume
24-05-09 66.73 -1.17% 587,636
24-05-08 67.52 +0.06% 283,195
24-05-07 67.48 -1.58% 512,837
24-05-06 68.56 +3.10% 1,005,625

End-of-day quote Shanghai S.E., May 08, 2024

More quotes
Hangzhou Alltest Biotech Co Ltd is a China-based company mainly engaged in the development and production of in vitro diagnostic reagents. The Company’s main products are rapid diagnostic reagents, including drug and drug abuse testing, infectious disease testing, women’s health testing, tumor testing, and heart marker testing. The Company's products are widely used in clinical testing, on-site testing and personal health management, especially in some new drug testing, new coronavirus testing, tropical infectious disease testing, respiratory all-in-one inspection, pediatric diarrhea all-in-one inspection and all-in-one joint inspection of fecal occult blood and other fields. The Company's main business is mainly distributed in overseas regions.
More about the company
  1. Stock Market
  2. Equities
  3. 688606 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW